Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Exscientia plc Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference August 28, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Business Update for Second Quarter and First Half 2024 August 15, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout July 18, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery July 10, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology June 06, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Present at Upcoming Investor Conferences in June May 30, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Business Update for First Quarter 2024 May 21, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Report First Quarter 2024 Financial Results on May 21, 2024 May 14, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Business and Financial Update for the Full Year 2023 March 21, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Report Full Year 2023 Financial Results on March 21, 2024 March 14, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Present at Upcoming Investor Conferences in March February 28, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients February 07, 2024 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme December 21, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza December 05, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference November 21, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Business Update for Third Quarter 2023 November 09, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023 November 02, 2023 From Exscientia plc Via Business Wire Tickers EXAI Parker Moss to Join Exscientia as EVP, Corporate Development October 17, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023 October 16, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Details Pipeline Prioritisation Strategy October 03, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany September 20, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Present at Upcoming Investor Conferences in September August 31, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Business Update for Second Quarter and First Half of 2023 August 10, 2023 From Exscientia plc Via Business Wire Tickers EXAI First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours July 10, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Present at the Goldman Sachs 44th Annual Global Healthcare Conference June 06, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Business Update for First Quarter 2023 May 24, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe May 22, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023 May 17, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage May 15, 2023 From Exscientia plc Via Business Wire Tickers EXAI Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors May 03, 2023 From Exscientia plc Via Business Wire Tickers EXAI Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.